Imerys (ENXTPA:NK) Is Up 8.1% After Swinging to Profit on Lower Sales in Q3 2025

• Imerys S.A. recently announced third quarter 2025 results, reporting sales of €827 million and net income of €39 million, a turnaround from a net loss of €285 million in the same period last year.

• This return to profitability occurred even as sales declined, highlighting significant cost control or operational improvements within the company.

• We'll explore how Imerys achieving positive net income amid lower sales impacts the company's outlook and investment narrative.

Outshine the giants: these 25 early-stage AI stocks could fund your retirement .

Imerys Investment Narrative Recap

Being a shareholder in Imerys today largely depends on the belief that the company can leverage its specialty minerals expertise to regain momentum from structurally weak end-markets and capitalize on eventual recovery in demand, all while managing project risks and capital intensity. The latest return to profitability in Q3 2025, even amid lower sales, signals some resilience but does not fundamentally shift the short-term catalyst of margin recovery or the key risk of delayed value creation from the EMILI lithium project; the news does not materially reduce concern over the project's economic viability at current lithium prices, nor does it resolve exposure to subdued construction and automotive markets.

Among recent company developments, the ongoing divestment of low-margin paper assets aligns with Imerys' focus on operational efficiency and margin improvement, the very strengths reflected in this quarter's earnings turnaround. This move sits squarely alongside the catalyst of profit growth built on a streamlined portfolio, which remains central to the company's next phase, especially with continuing headwinds in mature sectors.

Yet, against these operational gains, investors should still weigh how the EMILI lithium project's viability remains deeply sensitive to external pricing, as the real risk lies in…

Read the full narrative on Imerys (it's free!)

Imerys' outlook projects €3.8 billion in revenue and €405.1 million in earnings by 2028. This is based on an annual revenue growth rate of 3.6% and an earnings increase of €571.3 million from the current earnings of €-166.2 million.

Uncover how Imerys' forecasts yield a €27.40 fair value , a 21% upside to its current price.

Exploring Other Perspectives

Three Simply Wall St Community members currently estimate fair value for Imerys between €27.40 and €42.43 per share. With share price well below these views, the diverse outlooks highlight how confidence in operational improvements, like Q3's profit rebound, still competes with deep uncertainty about long-term growth and sector recovery.